IN BRIEF: Oxford BioDynamics raises GBP350,000 via retail offer

Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing ...

Alliance News 17 January, 2025 | 9:43PM
Email Form Facebook Twitter LinkedIn RSS

Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing products on market, the PSE prostate cancer screening test and the CiRT checkpoint inhibitor response test - Raises GBP350,000 via retail share offer at 0.5 pence per share. This is in addition to GBP7.0 million raised by placing and subscription at the same price, announced on Wednesday.

Proceeds will provide additional working capital and cash runway to support the continued commercial development of the EpiSwitch product line.

Oxford BioDynamics is currently undertaking a strategic review. Expects this to result in a greater focus on establishing partnerships, collaborations and licensing deals as a way of accelerating sales. As a result of this, company anticipates there will be a need to re-structure the business.

Current stock price: 0.60 pence, closed down 4.4% in London on Friday

12-month change: down 98%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Oxford BioDynamics PLC 0.65 GBX 3.33 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures